Previous close | 1.9300 |
Open | 1.9200 |
Bid | 1.9000 x 900 |
Ask | 2.2600 x 800 |
Day's range | 1.8900 - 1.9800 |
52-week range | 1.6000 - 7.0200 |
Volume | |
Avg. volume | 733,612 |
Market cap | 98.37M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.0970 |
Earnings date | 22 Feb 2022 - 28 Feb 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 31 Oct 2014 |
1y target est | 18.50 |
It's nice to see the Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) share price up 25% in a week. But that doesn't...
Participants on today's call are Evan Loh, M.D, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
We feel now is a pretty good time to analyse Paratek Pharmaceuticals, Inc.'s ( NASDAQ:PRTK ) business as it appears the...